- Home
- DNLI vs IQ Comparison
DNLI vs IQ Comparison
Compare DNLI & IQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- IQ
- Stock Information
- Founded
- DNLI 2013
- IQ 2009
- Country
- DNLI United States
- IQ China
- Employees
- DNLI N/A
- IQ N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- IQ Consumer Electronics/Video Chains
- Sector
- DNLI Health Care
- IQ Consumer Discretionary
- Exchange
- DNLI Nasdaq
- IQ Nasdaq
- Market Cap
- DNLI 2.1B
- IQ 1.7B
- IPO Year
- DNLI 2017
- IQ 2018
- Fundamental
- Price
- DNLI $13.92
- IQ $1.99
- Analyst Decision
- DNLI Strong Buy
- IQ Hold
- Analyst Count
- DNLI 15
- IQ 5
- Target Price
- DNLI $33.85
- IQ $2.60
- AVG Volume (30 Days)
- DNLI 1.5M
- IQ 19.8M
- Earning Date
- DNLI 08-04-2025
- IQ 08-20-2025
- Dividend Yield
- DNLI N/A
- IQ N/A
- EPS Growth
- DNLI N/A
- IQ N/A
- EPS
- DNLI N/A
- IQ 0.04
- Revenue
- DNLI N/A
- IQ $3,925,356,854.00
- Revenue This Year
- DNLI N/A
- IQ $2.04
- Revenue Next Year
- DNLI $323.34
- IQ $3.29
- P/E Ratio
- DNLI N/A
- IQ $53.78
- Revenue Growth
- DNLI N/A
- IQ N/A
- 52 Week Low
- DNLI $10.57
- IQ $1.50
- 52 Week High
- DNLI $33.33
- IQ $3.40
- Technical
- Relative Strength Index (RSI)
- DNLI 45.66
- IQ 62.14
- Support Level
- DNLI $13.70
- IQ $1.92
- Resistance Level
- DNLI $14.60
- IQ $2.13
- Average True Range (ATR)
- DNLI 0.65
- IQ 0.10
- MACD
- DNLI -0.06
- IQ 0.02
- Stochastic Oscillator
- DNLI 13.13
- IQ 59.72
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.